Trade TRDA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Entrada Therapeutics, Inc. (TRDA) is trading at US$7.27, up 3.86% today as of Aug 27, 16:00 EDT. The company has a market capitalisation of US$294.75M. Over the past 52 weeks, TRDA has traded between US$5.02 and US$16.45. On Syfe you can trade TRDA with $0 commission and add it to your watchlist.
| Previous close | US$7.00 |
|---|---|
| Market cap | US$294.75M |
| 52-week range | US$5.02 – US$16.45 |
| Volume | 248.59K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which provides of a class of medicines that engages in intracellular targets. Its Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. The company was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.
Year: 2021
HC Wainwright Downgrades Entrada Therapeutics to Neutral From Buy
May 8, 12:22 PM · MT Newswires
Sector Update: Health Care Stocks Softer Late Afternoon
May 7, 7:44 PM · MT Newswires
Sector Update: Health Care
May 7, 7:19 PM · MT Newswires
Entrada Therapeutics Shares Decline After Duchenne Muscular Dystrophy Drug Reportedly Misses Analyst Expectations
May 7, 6:43 PM · MT Newswires
Entrada Therapeutics, Inc. (TRDA) stock is trading at US$7.27, +3.86% from the previous close of US$7.00.
The market cap for Entrada Therapeutics, Inc. (TRDA) stock is approximately US$294.75M.
The 52-week high for Entrada Therapeutics, Inc. (TRDA) stock is US$16.45.
The 52-week low for Entrada Therapeutics, Inc. (TRDA) stock is US$5.02.
Entrada Therapeutics, Inc. (TRDA) does not currently pay a dividend.
Stay on top of TRDA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
